As part of Nuclear Medicine Europe’s commitment to develop closer working relationships with the European Association of Nuclear Medicine (EANM), we are pleased to announce our participation in the European Nuclear Medicine Forum to shape the future of Personalised Theranostics.
This 10-year initiative brings together experts in the field to develop a shared vision and strategic roadmap for the widespread integration of Personalised Theranostics into European healthcare systems by 2035.
The initiative is structured around five dedicated Task Forces. Nuclear Medicine Europe will co-lead two of these Task Forces, with Konrade von Bremen and Matt Morrison representing the association. Both will work alongside EANM clinical counterparts, ensuring the voice of the European nuclear medicine industry is clearly heard throughout the development process.
Further details will be shared at the General Assembly in June 2026.
Read more
EANM launches the European Nuclear Medicine Forum to shape the future of Personalised Theranostics